TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34043755
TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.The association between hearing impairment and polymorphisms of genes encoding inflammatory mediators in Japanese aged population.Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.THRB genetic polymorphisms can predict severe myelotoxicity after definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma.VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinomaTNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancer.Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.Identification of genetic variants in TNF receptor 2 which are associated with the development of cervical carcinoma.Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 1
P2860

TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34043755
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@ast
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@en
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@nl
type
label
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@ast
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@en
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@nl
prefLabel
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@ast
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@en
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
TNFRSF1B A1466G genotype is pr ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932